Metraipolis › archive › dc_6f7532bb8237

Reduction in Wearable-Derived Maximal Oxygen Consumption (VO₂max) During Tamsulosin Use in an Endurance Athlete — Europe PMC PMID:42367398

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42367398
DOI
10.7759/cureus.109685
License (as archived)
solo-consultazione
Archived
2026-11-01T06:51:31.835Z
SHA-256 of the archived text
18e4b62f12753472cb32565193f7fb601d8570eaa0ffc49f31b08a7b3aa2bccc
Stable URL of this page
https://metraipolis.com/documento/dc_6f7532bb8237

How to cite

Reduction in Wearable-Derived Maximal Oxygen Consumption (VO₂max) During Tamsulosin Use in an Endurance Athlete — Europe PMC PMID:42367398 — Europe PMC (en), https://europepmc.org/article/MED/42367398 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6f7532bb8237 (Metraipolis archive dc_6f7532bb8237, sha256 18e4b62f12753472cb32565193f7fb601d8570eaa0ffc49f31b08a7b3aa2bccc)
BibTeX
@misc{dc6f7532bb8237,
  title = {Reduction in Wearable-Derived Maximal Oxygen Consumption (VO₂max) During Tamsulosin Use in an Endurance Athlete — Europe PMC PMID:42367398},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42367398},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6f7532bb8237; sha256 18e4b62f12753472cb32565193f7fb601d8570eaa0ffc49f31b08a7b3aa2bccc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42367398. Agents can read the archived copy with the MCP tool read_document.